Efficacy variables included mycologic, clinical and combined outcomes. At the end of the study period, mycologic cures were recorded in 45, 50 and 52% of the fluconazole 3-week, fluconazole 6-week ...

mycologic and radiologic responses while maintaining a favorable safety/tolerability profile, with no all-cause mortality, no invasive pulmonary aspergillosis (IPA)-related mortality, and no TFF ...

Worldwide, cryptococcal meningitis kills up to 180,000 persons annually and is the most common cause of nonviral meningitis in the United States. Besides patients with immunosuppression due to ...

For TFF VORI, the Phase 2 trial and Expanded Access Program (EAP) data indicate that five out of six patients showed clinical response and mycologic response, with improvements in signs ...